▁London 8.296875
, 2.076171875
▁UK 1.66015625
▁- 2.408203125
▁Ant 8.828125
icip 3.359375
ation 1.125
▁is 0.9990234375
▁building 1.0517578125
▁within 5.69140625
▁the 0.12030029296875
▁medical 5.43359375
▁community 1.068359375
▁as 1.3125
▁anal 7.82421875
yst 0.04193115234375
s 0.0247039794921875
▁eager 5.49609375
ly 0.002254486083984375
▁await 0.1495361328125
▁new 4.58203125
▁evidence 5.1875
▁regarding 3.134765625
▁the 0.314453125
▁ground 7.7578125
- 1.3447265625
bre 0.0078125
aking 7.283687591552734e-05
▁anti 4.5546875
- 0.042083740234375
can 1.7470703125
cer 0.0005340576171875
▁treatment 2.369140625
, 1.7724609375
▁Mar 7.265625
im 5.73828125
ast 0.276123046875
at 7.176399230957031e-05
, 1.6044921875
▁developed 2.5859375
▁by 0.07989501953125
▁British 3.375
▁Bi 3.82421875
ote 0.0153350830078125
ch 0.3076171875
. 5.51171875
▁All 7.0
▁eyes 1.416015625
▁are 0.79736328125
▁on 0.5751953125
▁the 0.70947265625
▁up 2.7421875
coming 0.0185089111328125
▁European 3.91796875
▁Society 1.70703125
▁for 0.66552734375
▁Medical 0.05462646484375
▁On 0.005062103271484375
col 0.008941650390625
ogy 7.700920104980469e-05
▁( 0.436767578125
ES 0.020904541015625
MO 0.00042891502380371094
) 0.044830322265625
▁meeting 1.5947265625
▁where 3.26953125
▁the 1.298828125
▁latest 2.48046875
▁research 2.828125
▁on 1.7421875
▁this 2.169921875
▁potential 3.5
▁game 1.109375
- 0.1610107421875
ch 0.002773284912109375
anger 0.1861572265625
▁will 0.47412109375
▁be 0.0214080810546875
▁presented 0.363037109375
. 0.365234375
<0x0A> 0.1898193359375
Mar 1.080078125
im 0.003498077392578125
ast 0.0004787445068359375
at 0.00038051605224609375
▁has 2.548828125
▁been 0.740234375
▁creating 5.50390625
▁a 0.7939453125
▁bu 0.58935546875
zz 3.3736228942871094e-05
▁within 2.208984375
▁the 0.053955078125
▁scientific 2.50390625
▁community 0.0906982421875
▁due 2.123046875
▁to 0.00823211669921875
▁its 0.0478515625
▁potential 2.109375
▁to 0.2413330078125
▁revolution 0.9169921875
ize 0.12005615234375
▁cancer 0.7685546875
▁care 2.73046875
. 0.22119140625
▁The 1.03515625
▁treatment 2.126953125
, 1.8896484375
▁designed 5.05859375
▁to 0.89208984375
▁in 1.958984375
hib 0.003993988037109375
it 0.00023448467254638672
▁cancer 4.1328125
▁cell 0.927734375
▁growth 0.347412109375
▁and 1.34765625
▁met 3.32421875
ast 0.050506591796875
asis 0.028045654296875
, 0.066650390625
▁has 0.407470703125
▁shown 1.1923828125
▁remarkable 2.615234375
▁promise 2.09375
▁in 0.02142333984375
▁early 1.630859375
▁tri 1.1552734375
als 2.86102294921875e-05
. 1.3046875
▁However 2.779296875
, 0.0014705657958984375
▁detailed 7.44921875
▁evidence 2.890625
▁of 1.6328125
▁its 0.44482421875
▁effect 1.166015625
iveness 0.01142120361328125
▁remains 3.103515625
▁sc 3.83984375
ant 0.0088958740234375
, 0.93603515625
▁spark 4.9453125
ing 0.0005283355712890625
▁great 2.71484375
▁interest 0.95751953125
▁in 1.3994140625
▁the 0.322265625
▁forth 3.056640625
coming 0.0001093149185180664
▁ES 0.5361328125
MO 0.0001404285430908203
▁meeting 0.55029296875
. 0.2410888671875
<0x0A> 0.0787353515625
D 4.65625
uring 0.326171875
▁the 0.11181640625
▁virtual 6.5859375
▁event 1.232421875
, 0.10125732421875
▁scheduled 3.154296875
▁for 0.8134765625
▁next 6.25
▁month 1.1953125
, 0.0699462890625
▁British 4.765625
▁Bi 0.0802001953125
ote 0.0026702880859375
ch 0.0081024169921875
▁will 0.50048828125
▁present 0.5791015625
▁new 2.21484375
▁clin 2.697265625
ical 0.000972747802734375
▁data 0.51513671875
▁and 3.685546875
▁research 3.1953125
▁find 1.2685546875
ings 8.463859558105469e-06
▁that 2.294921875
▁del 5.90234375
ve 0.004238128662109375
▁deeper 0.72705078125
▁into 0.002819061279296875
▁the 0.2071533203125
▁potential 1.505859375
▁of 0.259765625
▁Mar 0.09716796875
im 0.00217437744140625
ast 0.0003662109375
at 0.0006947517395019531
. 0.476806640625
▁The 0.9609375
▁company 1.8330078125
' 1.8583984375
s 0.00017154216766357422
▁represent 4.15625
atives 0.00016057491302490234
▁aim 5.21484375
▁to 0.0021038055419921875
▁shed 2.330078125
▁light 0.25244140625
▁on 0.00199127197265625
▁the 0.2161865234375
▁treatment 1.1513671875
’ 4.875
s 3.5881996154785156e-05
▁effect 2.478515625
iveness 0.040191650390625
, 1.7099609375
▁safety 0.90673828125
▁profile 1.337890625
, 0.055389404296875
▁and 0.0328369140625
▁its 3.119140625
▁potential 0.73095703125
▁use 4.19921875
▁in 0.1868896484375
▁various 1.3857421875
▁cancer 0.409912109375
▁types 0.260498046875
. 0.1905517578125
<0x0A> 0.2188720703125
Anal 3.66796875
yst 0.01462554931640625
s 0.00531768798828125
, 4.01953125
▁invest 2.462890625
ors 0.0023517608642578125
, 0.0318603515625
▁and 0.047454833984375
▁medical 2.36328125
▁profession 0.28369140625
als 1.3828277587890625e-05
▁have 2.982421875
▁been 1.171875
▁closely 1.8017578125
▁following 1.125
▁the 0.27587890625
▁development 0.72265625
▁of 0.016998291015625
▁Mar 0.0673828125
im 0.0007476806640625
ast 0.0001709461212158203
at 0.00020122528076171875
▁for 2.54296875
▁its 4.25390625
▁potential 0.4443359375
▁impact 3.74609375
▁on 0.04644775390625
▁cancer 0.71337890625
▁treatment 1.2880859375
. 0.2003173828125
▁The 0.7177734375
▁anticip 4.37109375
ation 0.04400634765625
▁lies 7.84765625
▁not 2.578125
▁only 0.07110595703125
▁in 0.0244598388671875
▁the 0.29296875
▁hope 3.69140625
▁for 1.9755859375
▁a 0.352294921875
▁break 2.076171875
through 0.00020182132720947266
▁ther 2.83203125
apy 0.00013148784637451172
▁but 0.4619140625
▁also 0.08428955078125
▁the 2.943359375
▁potential 1.37890625
▁financial 4.4609375
▁imp 1.8076171875
lications 0.0075836181640625
▁for 1.5771484375
▁British 0.67578125
▁Bi 0.00244140625
ote 2.1219253540039062e-05
ch 0.00099945068359375
. 0.8310546875
<0x0A> 0.60400390625
Wh 3.501953125
ile 0.00862884521484375
▁the 0.751953125
▁effic 7.48828125
acy 8.487701416015625e-05
▁of 0.43994140625
▁Mar 0.387451171875
im 0.0008373260498046875
ast 0.00023996829986572266
at 0.0004467964172363281
▁will 4.59765625
▁be 0.442626953125
▁a 1.7705078125
▁key 1.0029296875
▁focus 0.61083984375
▁of 1.0595703125
▁the 0.22509765625
▁ES 0.487060546875
MO 8.797645568847656e-05
▁event 3.146484375
, 0.005214691162109375
▁exper 4.02734375
ts 4.4465065002441406e-05
▁also 2.052734375
▁keen 5.921875
ly 0.033538818359375
▁await 0.474853515625
▁any 2.9453125
▁updates 1.1474609375
▁on 0.340087890625
▁possible 6.4921875
▁side 4.3359375
▁effects 0.02777099609375
▁and 1.154296875
▁challeng 5.4921875
es 0.002178192138671875
▁associated 1.7626953125
▁with 0.0008435249328613281
▁its 1.521484375
▁use 0.68408203125
. 0.060211181640625
▁This 3.375
▁information 1.1748046875
▁will 1.255859375
▁be 0.370849609375
▁vital 2.79296875
▁for 1.5947265625
▁g 6.12890625
aug 0.0034580230712890625
ing 4.76837158203125e-06
▁its 1.986328125
▁potential 0.63232421875
▁as 1.599609375
▁an 3.16796875
▁effective 0.51708984375
▁treatment 1.3212890625
▁option 0.7236328125
, 2.572265625
▁ens 6.8984375
uring 7.402896881103516e-05
▁patient 3.03125
▁safety 0.0227508544921875
, 1.8525390625
▁and 0.018646240234375
▁inform 2.53515625
ing 0.00101470947265625
▁future 1.05859375
▁research 0.724609375
▁efforts 2.08984375
. 0.0765380859375
<0x0A> 0.029449462890625
The 1.46484375
▁up 2.228515625
coming 0.00017309188842773438
▁ES 0.2607421875
MO 9.97781753540039e-05
▁meeting 0.29052734375
▁promises 1.8662109375
▁to 0.0160675048828125
▁provide 2.841796875
▁a 1.248046875
▁significant 3.19140625
▁le 6.703125
ap 0.0021839141845703125
▁forward 0.0474853515625
▁in 0.10968017578125
▁our 1.8955078125
▁understanding 0.0352783203125
▁of 0.008026123046875
▁British 8.515625
▁Bi 0.002285003662109375
ote 0.00018990039825439453
ch 0.001544952392578125
' 0.56494140625
s 0.0004737377166748047
▁anti 2.451171875
- 0.00018453598022460938
can 0.0019893646240234375
cer 5.4001808166503906e-05
▁treatment 0.307861328125
, 0.433349609375
▁Mar 0.04803466796875
im 0.0003876686096191406
ast 8.07046890258789e-05
at 0.0001704692840576172
. 0.040191650390625
▁Anal 2.8125
yst 0.0009007453918457031
s 0.0008883476257324219
▁eager 2.986328125
ly 0.0034008026123046875
▁await 0.2115478515625
▁this 3.41015625
▁opportunity 2.0078125
▁to 0.037353515625
▁dig 5.578125
est 5.3671875
▁the 0.56103515625
▁new 2.50390625
▁data 1.2685546875
▁and 0.28271484375
▁explore 3.89453125
▁the 0.68505859375
▁potential 0.60595703125
▁applications 4.359375
▁of 0.18115234375
▁this 0.301025390625
▁cutting 3.49609375
- 0.0006413459777832031
edge 5.0902366638183594e-05
▁ther 0.432861328125
apy 3.7550926208496094e-05
. 0.19140625
